苏加马德克斯:一个老年心脏病患者的救世主! 一个案例报告报告
Gargi Deshpande1, Vandana Purandare1
1Department of Anaesthesiology, P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Saudi journal of anaesthesia
|November 27, 2024
概括
在患有心脏和肺部风险的老年患者中,Sugammadex有效地逆转了罗库. 这种方法最大限度地减少了血液动力学影响,证明了复杂手术的安全性.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 患有心脏和肺部风险的老年患者需要具有最小血动力学影响的麻醉剂.
- 罗库是一种常见的神经肌肉阻断剂,但在高风险患者中,其逆转需要仔细考虑.
- 苏加马德克斯是一种选择性放松剂结合剂,可以快速逆转罗库的作用.
研究的目的:
- 评估苏加马德克斯的安全性和有效性,以逆转罗库诱导的神经肌肉阻塞,在老年患者有显著的心脏和肺的并发症.
- 评估在高风险手术患者中施用sugammadex期间和之后的血液动力学稳定性.
主要方法:
- 一个83岁的男性患者接受了耳植入器手术的案例报告.
- 用于治疗神经肌肉阻塞的罗库的使用.
- 使用sugammadex扭转神经肌肉阻塞.
- 血液动力学参数的监测和肌肉效应的评估.
主要成果:
- 通过使用sugammadex成功并快速逆转罗库诱导的神经肌肉阻塞.
- 苏加马德克斯-罗库复合物是惰性的,导致最小的肌肉效应.
- 患者在整个外科手术期间保持血液动力学稳定.
- 没有观察到心脏或肺部不良事件.
结论:
- 苏加马德克斯 (Sugammadex) 在患有心脏和肺部风险因素的老年患者中提供了对罗库的安全和有效逆转剂.
- 苏加马德克斯的血动力学和肌肉性作用最小,使其成为高风险手术患者的首选选择.
- 这一案例突显了sugammadex在管理神经肌肉阻塞的成功使用,用于在患有重大并发症的患者中进行选择性手术.
相关概念视频
Heart Failure Drugs: Inotropic Agents
521
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
521
Skeletal Muscle Relaxants: Adverse Effects
335
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
335
Depolarizing Blockers: Pharmocokinetics
308
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
308


